Filing Details

Accession Number:
0001562180-23-000980
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-03 18:00:56
Reporting Period:
2023-02-01
Accepted Time:
2023-02-03 18:00:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762316 Vel Senthil Sundaram C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-30 3 $1.41 7,659 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2023-02-01 900,000 $0.00 900,000 $8.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
900,000 2033-01-31 No 4 A Direct
Footnotes
  1. Includes the purchase of 3 shares under the Terns Employee Stock Purchase Plan on November 30, 2022.
  2. 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.